microdosing glp-1 for menopause What to know when using hormone therapy and a together! GLP-1 Microdosing for Perimenopause and
Description
US Endocrinol
Rapid weight loss can disrupt the normal hair growth cycle, leading to a condition known as telogen effluvium
Why is my HRV lower since starting a GLP-1 even though I'm training
The Hansoh deal will let Merck compete in the crowded oral GLP-1 space alongside fellow pharma giants Eli Lilly, Novo Nordisk and Roche
Pharmacol Ther 239:108270
If phase 3 results remain positive, regulatory submissions may begin in 2026, meaning orforglipron could become available in late 2026 or 2027, depending on MHRA and NICE approval timelines
